Nordic HTA

Your market access partner from strategy to implementation

Nordic HTA is your Global Market Access partner

We combine our extensive experience within evidence generation, health economics, market access, and communication to support your market access goals.

1
Year
1
Succesful HTA submissions
1
Clients
1
Projects

Our services

  • Value generation strategy
  • Real World evidence
  • Systematic Literature Reviews
  • Statistical Analysis
  • Medical Writing
  • Publication Strategy
  • Early Modelling
  • Cost per Patient
  • Cost-Effectiveness
  • Budget-Impact
  • Payer Engagement Tools
  • Cost Of Illness
  • Value Demonstration Strategy
  • Pricing & Market Access Strategy
  • Value Proposition Development
  • Landscape & Situation Analysis
  • KOL Engagement & Planning
  • Cross-market Reimbursement/HTA submissions
  • Value Dossiers
  • Value Communication Strategy
  • Value Demonstration Tools
  • Effective Sales Implementation & Training
  • Publications

Excellence within

Be ready for the paradigm shift within MedTech HTA!

At Nordic HTA we have a strong team with extensive experience within MedTech HEOR and Market Access. We are your optimal partner for market access support from strategy to implementation.

We have extensive expertise within Orphan drugs and rare diseases HTA support.

We are your partner for pragmatic and manageable market access solutions for Orphan Drugs and Rare Diseases, such as Managed Entry Agreements and supportive Real World Evidence.

Patient-Centered Research

We have extensive expertise within Patient-Centered Research.

We are your partner for specialized support for any patient-centered need, from patient, clinician, and caregiver outcomes, utilities and preferences, adherence and other customized prospective observational study needs.

Latest news

Do you want to gain insight on market trends? Make sure to read the latest news from Nordic HTA.

Cross-functional Market Access course

We are proud to announce that Asger Lindvig will be delivering a session on the course “Cross-functional Market Access”, August 18-19th 2020. Together with Mark Friborg from the Danish Medicines…

New partner in Nordic HTA

We are very pleased to welcome Anders Mærkedahl to Nordic HTA. Prior to joining Nordic HTA, Anders Mærkedahl was the Global head of Health Economics & Market Access at Ambu…
Menu